GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • Ovid Technologies (Wolters Kluwer Health)  (2)
  • 1
    In: Otology & Neurotology, Ovid Technologies (Wolters Kluwer Health), Vol. 39, No. 4 ( 2018-04), p. e257-e262
    Abstract: The purpose was to explore the presence of myeloperoxidase (MPO)-deoxyribonucleic acid (DNA) complex as a surrogate marker of neutrophil extracellular traps (NETs) in the middle ear fluid, and to clarify the correlation between its quantifiable level and hearing outcome in patients with otitis media associated with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). Study Design: Prospective study. Setting: Tertiary referral center. Patients: Nine AAV patients presenting with otitis media. Intervention: Collection of the fluid samples from middle ear. Main Outcome Measure: The quantifiable levels of MPO-DNA complex using an enzyme-linked immunosorbent assay. Results: The quantifiable levels of MPO-DNA complex in patients with AAV were significantly higher than those in controls ( p   〈  0.001). In particular, both ANCA-positive and -negative cases indicated higher levels of MPO-DNA complex compared with the controls ( p  = 0.004 and p  = 0.006, respectively). The significant negative correlations were observed between the level of MPO-DNA complex and the functional hearing values for air ( r  = −0.82, p  = 0.009) and bone conduction ( r  = −0.73, p  = 0.028), respectively. Conclusion: This analysis is the first to reveal the presence of elevated levels of MPO-DNA complex in the middle ear fluid, suggesting the pathogenic role of NETs in otitis media associated with AAV. NETs may be a valuable biomarker for use in clinical decision-making and predicting hearing outcome, regardless of ANCA status.
    Type of Medium: Online Resource
    ISSN: 1531-7129 , 1537-4505
    Language: English
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date: 2018
    detail.hit.zdb_id: 2058738-7
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    In: Otology & Neurotology, Ovid Technologies (Wolters Kluwer Health), Vol. 40, No. 2 ( 2019-02), p. e99-e106
    Abstract: This prospective study aimed to evaluate the diagnostic and clinical utility of the myeloperoxidase (MPO)–DNA complex as a NETosis-derived product in the middle ear fluid of patients with otitis media with antineutrophil cytoplasmic antibody-associated vasculitis (OMAAV). Study Design: Prospective study. Setting: Tertiary referral center. Patients: Twenty-two patients diagnosed with OMAAV. Intervention: Collection of the fluid samples from middle ear. Main Outcome Measure: The levels of the MPO–DNA complex in the fluid samples were quantified using an enzyme-linked immunosorbent assay. Results: Patients with both systemic and localized forms of OMAAV showed significantly higher levels of the MPO–DNA complex compared to the controls ( p   〈  0.001 and p  = 0.002, respectively). In particular, they showed significantly higher levels of MPO–DNA complex compared to the controls, regardless of serum antineutrophil cytoplasmic antibody status ( p   〈  0.001 and p   〈  0.001, respectively) or immunosuppressive therapy ( p   〈  0.001 and p   〈  0.001, respectively) at the time of sampling. An optical density cutoff value of 0.16 at 405 nm according to the receiver operating characteristic curve showed a sensitivity of 86.4%, specificity of 95.5%, positive predictive value of 95.0% and negative predictive value of 87.5% for the diagnosis of OMAAV. Significant positive correlations were observed between the levels of MPO–DNA complex and the values for air conduction – ( r  = 0.49, p  = 0.022) and bone conduction – pure tone average thresholds ( r  = 0.45, p  = 0.035). Conclusions: The detection and quantification of the MPO–DNA complex in the otitis media fluid may aid in providing a definite diagnosis as well as predicting the activity and severity of OMAAV.
    Type of Medium: Online Resource
    ISSN: 1531-7129 , 1537-4505
    Language: English
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date: 2019
    detail.hit.zdb_id: 2058738-7
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...